Page last updated: 2024-10-29
indomethacin and Inferior Dislocation
indomethacin has been researched along with Inferior Dislocation in 1 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Research Excerpts
Excerpt | Relevance | Reference |
"Indomethacin, 25 mg, was given three times daily for six weeks." | 2.69 | Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: a randomised, prospective study. ( Anglen, JO; Goss, K; Moore, KD, 1998) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Moore, KD | 1 |
Goss, K | 1 |
Anglen, JO | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
External Beam Radiotherapy as Prophylaxis for Heterotopic Ossification After Surgical Fixation of Acetabular Fractures: a Prospective, Randomized Feasibility Study[NCT04867278] | | 60 participants (Anticipated) | Interventional | 2021-05-09 | Enrolling by invitation |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for indomethacin and Inferior Dislocation